Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Novacap, a worldwide player in pharmaceutical synthesis and advanced specialties, announced today that it has signed an agreement to acquire Boston-based PCI Synthesis, a leading U.S. pharmaceutical contract development and manufacturing organization...
read more
Tuesday, November 29, 2016
Vigene Biosciences, a biotechnology company focused on viral vector production and development, has entered into a definitive agreement to acquire the assets of Omnia Biologics, Inc. (Omnia), including Omnia's cGMP facility and equipment. The ...
read more
Tuesday, November 28, 2023
Thermo Fisher Scientific Inc. and Flagship Pioneering have unveiled a strategic partnership aimed at the rapid development and commercial scaling of multiproduct platforms.
read more
Piramal Pharma Solutions announced a $90M investment plan to expand two of its U.S. facilities, which are critical to its integrated offering. This ambitious investment underscores the company's commitment to industry leadership through continuous ...
read more
Wednesday, January 08, 2020
Pfenex announced that Serum Institute achieved WHO prequalification for Pneumosil, a 10-valent pneumococcal conjugate vaccine.
read more
Trovagene has executed a supplier agreement with NerPharMa, to manufacture drug product for PCM-075.
read more
Wednesday, October 14, 2015
Piramal Enterprises' Pharma Solutions division, a global contract development and manufacturing organization (CDMO), has delivered its comprehensive review of the injectables market – both sterile and small molecule – for the next 5 years during its ...
read more
-- 100 Contract Research and Contract Manufacturing Organizations will be exhibiting at this year's September 17-19, 2013 Pharma ChemOutsourcing Show at the Jersey Shore reported Apaporis LLC, the organizer. The companies offer a wide range of ...
read more
Thursday, November 09, 2023
Alloy Therapeutics, Inc., a biotechnology ecosystem company and Wheeler Bio, Inc., an agile contract development and manufacturing organization (CDMO), announced the formation of a non-exclusive, preferred service offering to drive translation from ...
read more
Tuesday, January 15, 2019
Pharmaceutics International, Inc. (Pii) announced the appointment of Kurt R. Nielsen, Ph.D., to the position of President and CEO, effective immediately.
read more
Veeva Systems announced Tom Schwenger will join the company as president and COO in September 2019 to lead strategy, sales, and services.
read more
GeneCentric Therapeutics has acquired Select ImmunoGenomics, a Chapel Hill, NC-based provider of advanced immunogenomic, data analysis and biomarker development services to support the development of immuno-oncology drugs. The acquisition provides ...
read more
SCA Pharmaceuticals has entered into a definitive membership interest purchase agreement with The Vistria Group and Excellere Capital Management.
read more
Friday, February 07, 2020
Navrogen and Levena Biopharma announced the expanded collaboration to develop ADCs targeting humoral immuno-suppressed cancers.
read more
Friday, September 23, 2016
Cryoport has announced the integration of its proprietary logistics technology, the Cryoportal™, with Database Integrations, Inc.'s Integrated Cell Therapy Automated Network (iCAN) scheduling platform.
read more